SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 28, 13:55
440.70
3.5 (0.8%)
VOLUME 55,476
LIVE
NSE
Feb 28, 13:55
440.75
3.15 (0.72%)
VOLUME 769,782
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila scouts for acquisitions, bets on US specialty biz

6.32 pm | 27 Feb 2017 |  Source: Moneycontrol.com

The company said the ramping up of its specialty portfolio would initially focus on acquisitions, as developing a product would take around three year...

Cadila arm gets nod for generic anti-viral, anti-bacterial drugs

3.17 pm | 27 Feb 2017 |  Source: Moneycontrol.com

Oseltamivir Phosphate capsules also market by Roche under brand name Tamiflu is anti-viral pill used in the prevention and treatment of influenza viru...

Zydus' Nesher Pharmaceuticals receives final approval for Oseltamivir Phosphate capsules

12.36 pm | 27 Feb 2017 |  Source: Moneycontrol.com

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Oseltamivir Phosphate Capsules,...

Cadila Health up 3% on product launch & USFDA nod to skin drug 

11.52 am | 27 Feb 2017 |  Source: Moneycontrol.com

Cadila’s subsidiary, Zydus Cadila, received regulatory approvals to launch tetravalent inactivated influenza vaccine for seasonal flu in India. Mean...

'Stocks to trend higher but BJP loss in UP may spark correction' 

11.27 am | 27 Feb 2017 |  Source: CNBC-TV18

The market is likely to correct if the BJP loses state elections in Uttar Pradesh, he said. The effect on the market, he said, will depend on the quan...

Here are Sanjiv Bhasin's top trading ideas 

10.25 am | 27 Feb 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Sanjiv Bhasin of IIFL shared his reading and outlook on the market and ...

Stocks in news: Coal India, ONGC, L&T, Canara Bank, Bajaj Hind 

8.04 am | 27 Feb 2017 |  Source: Moneycontrol.com

Coal India | ONGC | L&T | Canara Bank | Bajaj Hind | Tata Power | Jain Irrigation | Amtek Auto | Jindal Stainless | Inox Leisure | IL&FS Engineering |...

Drug cos focus on automation & work culture to meet compliance

9.20 pm | 24 Feb 2017 |  Source: Moneycontrol.com

Faced with increasing regulatory scrutiny -- Indian drug makers working more closely then ever before on Friday said they have been investing on autom...

Pharma body comes up with new guidelines on data integrity

9.27 pm | 23 Feb 2017 |  Source: Moneycontrol.com

Data reliability or data integrity are often linked to allegations of data falsification or manipulation, which are cited as main reasons by US FDA fo...

Buy Cadila Healthcare, target Rs 460: Mitessh Thakkar

4.26 pm | 23 Feb 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests buying Cadila Healthcare with a minimum target of Rs 460....

Buy DCB Bank, Cadila Health, IndusInd Bk, Grasim: Gujral 

2.41 pm | 23 Feb 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com suggests buying DCB Bank, Cadila Healthcare, IndusInd Bank and Grasim Industries....

Buy Wipro, Cadila Healthcare: Mitessh Thakkar 

2.40 pm | 23 Feb 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com recommends buying Wipro and Cadila Healthcare....

Cadila Health: Zydus gets USFDA nod for Phase II clinical trial of Saroglitazar

1.16 pm | 23 Feb 2017 |  Source: Moneycontrol.com

Zydus Cadila announced that the USFDA has approved the groups plan to initiate a Phase 2 clinical trial of Saroglitazar Magnesium in patients with Pr...

Hot on the charts: Buy Cadila Health, Exide, M&M Fin, says Kotak

9.56 am | 22 Feb 2017 |  Source: Moneycontrol.com

M&M Finance stock has formed an Inverse Head & Shoulder pattern at the bottom, which is a reversal formation. It is on the verge of break-out and risi...

Stocks in news: Dr Reddy's, ITC, TCS, BEL, Axis, BPCL, Disa, ITD

8.00 am | 22 Feb 2017 |  Source: CNBC-TV18

Dr Reddy's Labs | ITC | Infosys | TCS | Tata Motors | Bharat Electronics | Power Grid | Axis Bank | ONGC | HPCL | BPCL | Castrol India | Castex Techno...

Hold Cadila Healthcare; target of Rs 425: ICICI Direct

3.26 pm | 21 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 425 in its research report dated February 17, 2017....

Buy Cadila Healthcare; target of Rs 510: Motilal Oswal

3.14 pm | 21 Feb 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 510 in its research report dated Febru...

Here is why SP Tulsian is bullish on Petronet LNG 

7.40 pm | 17 Feb 2017 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com, explains why he is bullish on Petronet LNG. He also discusses key pharma sector likes Cadila Healthcare, Divis Laboratori...

Market looks good from 3-5 year perspective: IIFL 

3.35 pm | 17 Feb 2017 |  Source: CNBC-TV18

India Infoline Founder and Chairman Nirmal Jain said the market looks good from a 3-5 year perspective. His optimism stems for the investor inflows in...

Look at pharma with 2-3 yr view; prefer pvt banks: UTI MF 

3.22 pm | 17 Feb 2017 |  Source: CNBC-TV18

Market in yesterday’s trade rallied owing to the gains from healthcare stocks. Swati Kulkarni of UTI MF said that pharma companies are going through...

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.